Related Experiment Video
Updated: Jul 31, 2026

Intravenous Microinjections of Zebrafish Larvae to Study Acute Kidney Injury
Published on: August 4, 2010
Intravenous azithromycin-induced ototoxicity
E D Bizjak1, M T Haug, R J Schilz
1College of Pharmacy, University of Arizona, USA.
Abstract:
Intravenous azithromycin is increasingly administered for treatment of hospitalized patients with community-acquired pneumonia. Macrolide antibiotics cause ototoxicity, which occurs most frequently when high serum concentrations are achieved. Current dosing guidelines for intravenous azithromycin can result in much higher serum concentrations than is seen with oral administration. We describe a 47-year-old woman who developed complete deafness after receiving 8 days of intravenous azithromycin.
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Endocarditis III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Mechanism of Antibiotic Resistance in MRSA
Cryptococcal Meningitis

